| 标题 |
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:J. Guigay; Anne Aupérin; Jérôme Fayette; Esma Saâda-Bouzid; Cédrik Lafond; et al 出版日期:2021-03-07 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)